Get FREE shipping on all orders over $150. SHOP NOW


0 items


Luff Enterprises Announces Final Health Canada License Approval for the NG Biomed Group of Companies

Written by
Luff Enterprises Announces Final Health Canada License Approval for the NG Biomed Group of Companies

Luff Enterprises Announces Final Health Canada License Approval for the NG Biomed Group of Companies

Vancouver, B.C. – Luff Enterprises Ltd., (CSE: LUFF) (“LUFF” or the “Company”) is pleased to provide a further update on its previously announced agreement to acquire the National Green Biomed group of companies (“NG Biomed”). On July 21, 2022 Luff announced its plan to acquire, largely for share consideration, NG Biomed, a licensed producer of cannabis products for both the recreational and medical consumer markets.

Luff announces that NG Biomed’s wholly owned subsidiary, Rosebud Productions Inc., has received final approval from Health Canada to authorize the activity of sale of cannabis extracts, edible cannabis, and cannabis topical products to provincially and territorially authorized retailers and holders of a licence for sale for medical purposes.

This approval was the final step in NG Biomed’s licence approval process, and will allow for a complete product offering for clients. It will also facilitate more streamlined procurement and fulfilment operations when medical sales are initiated. 

Luff’s CEO, Philip Campbell, remarked, “The sales licence approval for extracts is the culmination of months of hard work and determination by the team at National Green Biomed, with a relentless focus on quality and consistency. With our new sales platform for medical products in Canada ramping up, this approval paves the way for Luff to expand the products that we are bringing to market, in addition to our proposed best-in-class craft flower menu.”

The acquisition of NG Biomed remains subject to approval from NG Biomed’s shareholders, approval from the Canadian Securities Exchange, if needed, and completion of customary closing conditions.


LUFF is a hemp and wellness company, focused on providing premium quality, innovative products across the United States through its online store. Committed to plant-based science, LUFF produces and sources a suite of thoughtfully designed products to benefit a wide range of user needs.

Currently, the Company focuses on identifying unique products and formulations leveraging cannabinoids to empower people to realize the full potential of everyday life. LUFF’s scientifically formulated products are non-GMO, THC-free, 3rd party tested, and only crafted with hemp grown in the United States.


Philip Campbell, CEO and Director
Telephone: 250-419-7665

Related Posts

Herbal Dispatch Announces 2023 Third Quarter Financial Results With Continued Strong Revenue Growth
• Achieved gross revenue of $1.5 million in Q3 2023, which represented domestic sales growth of 45% from Q2 2023;• Ex...
Read More
Herbal Dispatch Announces 2023 Second Quarter Financial Results
- Achieved gross sales of $1.4 million in Q2 2023, representing growth of 260% from Q1 2023- Completed first export s...
Read More
Herbal Dispatch Completes First Export Sale to Australia
Vancouver, B.C. – Herbal Dispatch Inc. (CSE: HERB) (“Herbal Dispatch” or the “Company”) is pleased to announce it has...
Read More
Back to all posts